Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127751131 | 12775113 | 1 | I | 20150101 | 20151105 | 20160923 | 20160923 | PER | US-PFIZER INC-3073787 | PFIZER | 73.00 | YR | F | Y | 0.00000 | 20160923 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127751131 | 12775113 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | UNK | U | UNK | 76517 | SOLUTION FOR INJECTION | ||||||||
| 127751131 | 12775113 | 2 | SS | CETUXIMAB | CETUXIMAB | 1 | UNK | U | UNK | 0 | |||||||||
| 127751131 | 12775113 | 3 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | UNK | U | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127751131 | 12775113 | 1 | Acinic cell carcinoma of salivary gland |
| 127751131 | 12775113 | 2 | Acinic cell carcinoma of salivary gland |
| 127751131 | 12775113 | 3 | Acinic cell carcinoma of salivary gland |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127751131 | 12775113 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127751131 | 12775113 | Disease progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |